Primer in Nutritional Psychiatry: MGH Certification In Nutrition & Mental Health

Primer in Nutritional Psychiatry: MGH Certification In Nutrition & Mental Health

Program Agenda 

Module I: Introduction to Nutritional Psychiatry Basic Principles | Umadevi Naidoo, MD

• Background & History of Nutritional Psychiatry
• The Gut Brain Ecosystem
• Functions of a Healthy Gut
• Patient Engagement in Nutritional Psychiatry
• Pre-treatment assessment. Patient Engagement. Data tracking

Module II: Depression and Anxiety | Umadevi Naidoo, MD

• Inflammation as an underlying mechanism
• Depression and related research
• Anxiety and related research
• Review of the research behind studies which support the use of food to help improve depression and anxiety
• Foods that impact mood and anxiety

Module III: Memory and Insomnia | Umadevi Naidoo, MD

• The gut and memory: review the research
• The MIND Diet • Foods that weaken memory
• Foods that protect memory
• Describe foods that cause insomnia and how to eat to help insomnia
• Foods that Disrupt Sleep
• Foods to Support Sleep
• Sleep Hygiene

Module IV: Trauma and OCD | Umadevi Naidoo, MD

• Trauma and your gut
• PTSD and the ‘Old Friends’ Bacteria
• Foods that Deepen Trauma
• Foods that Soothe Trauma
• OCD and The Gut
• Foods that Worsen OCD and Foods & Supplements that Help OCD
• Orthorexia

Module V: Major Mental Illnesses & Nutritional Strategies | Umadevi Naidoo, MD

• The Gut in Bipolar Disorder
• Foods that Harm Bipolar Disorder
• Mood Stabilizing Foods & Supplements
• The Gut in Schizophrenia
• Foods that Worsen Schizophrenia
• Reality Re-Setting Foods

Module VI: Integrating this Model of Care | Umadevi Naidoo, MD

• Program Overview
• Depression, Anxiety, Insomnia
• OCD, Bipolar Disorder, ADHD & Focus
• Healthy Fats, Fiber, Polyphenol, Antioxidants
• How to use nutritional interventions in clinical practice

Module VII: MGH Nutritional Psychiatry Interviews 

• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. Emeran Mayer, MD
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. David Perlmutter, MD, FACN
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. Dean Ornish, MD
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Rudolph E. Tanzi, PhD
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. Andrew E. Budson, MD
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. Jeffrey S. Bland, PhD, FACN, CNS
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. Mark A. Hyman, MD
• MGH Nutritional Psychiatry Interview with Dr. Uma Naidoo, MD & Dr. Kenneth R. Pelletier, MD, PhD

Faculty: 

Jeffrey S. Bland, PhD, FACN, CNS
Dr. Bland is an internationally recognized leader in the nutritional medicine field. He co-founded The Institute for Functional Medicine in 1991 and is known to many as the “father of Functional Medicine.” Over the past 35 years, Dr. Bland has traveled more than six million miles teaching more than 100,000 healthcare practitioners in the US, Canada, and 50 other countries about Functional Medicine.

A biochemist by training, Dr. Bland is a fellow of the both the American College of Nutrition, where he is a certified nutrition specialist, and the Association for Clinical Biochemistry. Dr. Bland served as director of nutritional research at the Linus Pauling Institute of Science and Medicine in the early 1980’s, working directly with two-time Nobel Laureate Dr. Linus Pauling, whom he considers his lifelong mentor. Dr. Bland has authored several books about nutritional medicine, both for the healthcare professional and for the general public, and he is also the principal author of over 120 peer-reviewed research papers on nutritional biochemistry and medicine. Dr. Bland has self-published a monthly audio journal, Functional Medicine Update, for more than 30 years that is distributed to healthcare practitioners in 36 countries.

Dr. Bland was the founder and chief executive officer of HealthComm International, a global company that became a leader in the development of medical foods; chief science officer of Metagenics, Inc.; and president of MetaProteomics, where he led a research team of more than 100 scientists in studying metabolic factors associated with chronic diseases. In 2012, Dr. Bland founded the Personalized Lifestyle Medicine Institute (PLMI), a nonprofit organization based in Seattle, Washington, where he continues to serve as president. He is also president and CEO of KinDex Therapeutics, which researches molecules associated with genetic expression patterns in chronic diseases.

Andrew E. Budson, MD
Andrew E. Budson, MD majored in chemistry and philosophy at Haverford College before receiving his medical degree from Harvard Medical School. Dr. Budson is Professor of Neurology at Boston University, Lecturer in Neurology at Harvard Medical School, and Chief of Cognitive & Behavioral Neurology at the Veterans Affairs Boston Healthcare System. His career combines education, research, and clinical care to help those with memory disorders. Budson is also the author of Seven Steps to Managing Your Memory and Six Steps to Managing Alzheimer’s Disease and Dementia, both also available from Oxford. 

Mark Hyman MD
Dr. Hyman has turned his passion for Functional Medicine, real food, nutrition, and wellness into activism, working to change our food system on a global scale. Through his work to change policy for the betterment of public health, Dr. Hyman has testified before the Senate Working Group on Health Care Reform on Functional Medicine. He has consulted with the surgeon general on diabetes prevention and participated in the 2009 White House Forum on Prevention and Wellness. Senator Tom Harkin of Iowa nominated Dr. Hyman for the President’s Advisory Group on Prevention, Health Promotion, and Integrative and Public Health. Additionally, Dr. Hyman has presented at the Clinton Foundation’s Health Matters, Achieving Wellness in Every Generation conference and the Clinton Global Initiative, as well as with the World Economic Forum on global health issues, TEDMED and TEDx. He is the winner of the Linus Pauling Award and the Nantucket Project Award. Dr. Hyman received the Christian Book of the Year Award for his work on The Daniel Plan, a faith-based initiative that helped Saddleback Church collectively lose 250,000 pounds that he created with Rick Warren, Dr. Mehmet Oz, and Dr. Daniel Amen. He was also inducted into the Books for Better Life Hall of Fame With Dr. Dean Ornish and Dr. Michael Roizen. Dr. Hyman crafted and helped introduce the Take Back Your Health Act of 2009 to the United States Senate, which promotes reimbursement for lifestyle treatment of chronic disease. With Tim Ryan in 2015, he helped introduce the ENRICH Act into Congress to fund nutrition in medical education. Dr. Hyman plays a substantial role in the major 2014 film Fed Up, produced by Laurie David and Katie Couric, which addresses childhood obesity.

Dean Ornish, MD
Dr. Ornish is the founder and president of the non-profit Preventive Medicine Research Institute and Clinical Professor of Medicine at UCSF and at UCSD. For over 40 years, he has directed clinical research demonstrating, for the first time, that comprehensive lifestyle changes may begin to reverse the progression of even severe coronary heart disease and also early-stage prostate cancer as well as other chronic diseases. 
 
In 2010, CMS created a new Medicare benefit category to cover his reversing heart disease program, and it is now covering this when offered virtually via Zoom nationwide.  He is currently directing the first randomized controlled trial to determine if these intensive lifestyle changes may stop or reverse the progression of early-stage Alzheimer’s disease.  
 
He is a #1 New York Times bestselling author of seven books.  His three main-stage TED.com talks have been viewed by over seven million people.  
 
He was appointed by President Clinton and also by President Obama to White House Advisory Commissions and by Governor Newsom and Maria Shriver to the Governor’s Brain Trust on Alzheimer’s Disease Prevention and Preparedness.  He is also a member of The Lancet Oncology “Moonshot Commission” and has been a member of the board of directors of the San Francisco Food Bank.
 
The “Ornish diet” has been rated “#1 for Heart Health” by a panel of experts at U.S. News & World Report for 11 years from 2011-2022.  He co-chaired the Google Health Advisory Council 2007-9.  
 
He was recognized as “one of the 125 most extraordinary University of Texas alumni in the past 125 years;” a “National Public Health Hero” award from the University of California, Berkeley; the Beckmann Medal from the German Society for Prevention and Rehabilitation of Cardiovascular Diseases; by TIME magazine as a “TIME 100 Innovator;” by LIFE magazine as “one of the fifty most influential members of his generation;” by People magazine as “one of the most interesting people of the year;” and by Forbes magazine as “one of the world’s seven most powerful teachers.” www.ornish.com & www.PMRI.org & www.undoitbook.com

Emeran A. Mayer, MD
Emeran A Mayer is a Gastroenterologist, Neuroscientist and Distinguished Research Professor in the Department of Medicine at the David Geffen School of Medicine at UCLA, the Executive Director of the G. Oppenheimer Center for Neurobiology of Stress & Resilience at UCLA and Founding Director of the Goodman Luskin Microbiome Center at UCLA. He is one of the pioneers and leading researchers in the bidirectional communication within the brain gut microbiome system with wide-ranging applications in intestinal and brain disorders. He has published 410 scientific papers, co edited 3 books, published the best selling The Mind Gut Connection book in 2016 and the Gut Immune Connection book in June 2021, and is currently working on a PBS documentary about the mind gut connection.  He is the recipient of numerous awards, including the 2016 David McLean award from the American Psychosomatic Society and the 2017 Ismar Boas Medal from the German Society of Gastroenterology and Metabolic Disease.  

Kenneth R. Pelletier, PhD, MD
Dr. Pelletier is a Clinical Professor of Medicine, Department of Medicine; Department of Family and Community Medicine, and Department of Psychiatry at the University of California School of Medicine (UCSF) in San Francisco. At the University of California School of Medicine, he is Director of the Corporate Health Improvement Program (CHIP) which is a collaborative research program between CHIP and 15 of the Fortune 500 corporations including Ford, Oracle, Prudential, Apple, Dow, Lockheed Martin, NASA, Pepsico, IBM, American Airlines, and NASA. He also serves as Chairman of the American Health Association (AHA) and is a Vice President with American Specialty Health (ASH).
 
Prior to these positions, from 2001 to 2016, Dr. Pelletier served as Clinical Professor of Medicine in the Department of Medicine, Department of Family and Community Medicine and Professor of Public Health, at the University of Arizona School of Medicine. From 1990 through 2001, Dr. Pelletier was a Clinical Professor of Medicine at the Stanford University School of Medicine; was Director of the Stanford Corporate Health Improvement Program (SCHIP); and, Director of the NIH funded Complementary and Alternative Medicine Program at Stanford (CAMPS). From 1974 until joining the Stanford University School of Medicine in 1990, Dr. Pelletier held a dual appointment as an Associate Clinical Professor in the Department of Medicine and in the Department of Psychiatry, at the University of California School of Medicine (UCSF) in San Francisco. In addition to his faculty positions, Dr. Pelletier has served as a member of the Board of Directors and Chairman of the California Wellness Foundation, Foundation Health Systems (FHS), Health Systems International (HSI), Health Net, and the Social Venture Network. He was a Woodrow Wilson Fellow, studied at the CG Jung Institute in Zurich, Switzerland and has published over 300 professional journal articles in behavioral medicine, disease management, worksite interventions, alternative/integrative medicine, and epigenetics. 
 
At the present time, Dr. Pelletier is a medical and business consultant to the US Department of Health and Human Services, the World Health Organization (WHO), the National Business Group on Health, the Federation of State Medical Boards, and major corporations including Cisco, IBM, American Airlines, Prudential, Dow, Disney, Ford, Mercer, Merck, Pepsico, Ford, Pfizer, Walgreens, NASA, Microsoft ENCARTA, Blue Cross/Blue Shield, United Healthcare, Health Net, the Pasteur Institute of Lille, France, the Alpha Group of Mexico, and the Singapore Ministry of Health

David Perlmutter, MD, FACN, ABIHM
Dr. Perlmutter is a Board-Certified Neurologist and six-time New York Times bestselling author. He serves on the Board of Directors and is a Fellow of the American College of Nutrition. 

Dr. Perlmutter received his M.D. degree from the University of Miami School of Medicine where he was awarded the Leonard G. Rowntree Research Award. He serves as a member of the Editorial Board for the Journal of Alzheimer’s Disease and has published extensively in peer-reviewed scientific journals including Archives of Neurology, Neurosurgery, and The Journal of Applied Nutrition. In addition, he is a frequent lecturer at symposia sponsored by institutions such as the World Bank and IMF, Columbia University, Scripps Institute, New York University, and Harvard University and serves as an Associate Professor at the University of Miami Miller School of Medicine. 

Dr. Perlmutter’s books have been published in 32 languages and include the #1 New York Times bestseller Grain Brain, The Surprising Truth About Wheat, Carbs and Sugar, with over 1 million copies in print. Other New York Times bestsellers include Brain Maker, The Grain Brain Cookbook, The Grain Brain Whole Life Plan, and Brain Wash, co-written with Austin Perlmutter, M.D. He is the editor of The Microbiome and the Brain authored by top experts in the field and published in December2019 by CRC Press. His latest New York Times bestselling book, Drop Acid, focuses on the pivotal role of uric acid in metabolic diseases.

Rudolph Tanzi, MD
Dr. Tanzi is the Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, Co-Director of the Henry and Allison McCance Center for Brain Health, and Co-Director of the MassGeneral Institute for Neurodegenerative Disease at Massachusetts General Hospital. He also serves as the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School. Dr. Tanzi received his B.S. (microbiology) and B.A. (history) at the University of Rochester in 1980 and his Ph.D. (neurobiology) at Harvard Medical School in 1990. 

Dr. Tanzi was a key member of the teams that discovered the first Alzheimer’s disease (AD) gene, the amyloid precursor protein (APP) gene, and the two other early-onset familial AD genes, presenilin 1 and presenilin 2. As leader of the Cure Alzheimer’s Fund Alzheimer’s Genome Project, Dr. Tanzi identified several other AD genes, including CD33, the first AD gene shown to regulate neuroinflammation in AD. He also discovered the Wilson’s disease gene and several other neurological disease genes.

Dr. Tanzi serves as Chair of the Cure Alzheimer’s Fund Research Leadership Group and on numerous scientific advisory and editorial boards, He has published over 600 research papers and is one of the top 50 most cited neuroscientists in the world. He has received the highest awards in his field, including the Metropolitan Life Foundation Award, Potamkin Prize, Ronald Reagan Award, Oneness in Humanity Award, Silver Innovator Award, the Smithsonian American Ingenuity Award, the Brain Research Foundation Award, and the Kary Mullis Award for Medical Research. He has also been named to TIME magazine’s list of TIME100 Most Influential People in the World. Dr. Tanzi is also a New York Times bestselling author, who has co-authored the books Decoding Darkness, and bestsellers, Super Brain, Super Genes, and The Healing Self.

Course Director 

Umadevi Naidoo, MD

Speakers

Umadevi Naidoo, MD

 Planners

• Uma Naidoo MD
• David H. Rubin, MD
• Jane Pimental, MPH

Reviewers

• David H. Rubin, MD, Content Reviewer
• Susan Sprich, PhD, Psychologist Reviewer

Financial Relationships

The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months: 

Jeffrey Bland, PhD
Board Member/President: Big Bold Health, Inc. 

Andrew Budson, MD
Paid Consultant: Eli Lilly, Genentech
Royalties: Oxford University Press; Elsevier

Mark Hyman, MD
Executive Role/Stock Holder: Function Health
Advisor/ Stock Option: Salvo Health
Advisor: Fountain Life; Rosebar
Owner: Vitamin Portfolio LLD; Farmacy LLC
Advisor/ Stock Holder: Big Bold Health, LifeForce, Performance Kitchen

Emeran Mayer, MD
External Advisory Board Member: Seed
Consultant: Danone; Amare; Mahana Therapeutics; Pendulum; Bloom Biosciences; APC Ireland 

Dean Ornish, MD
Consultant: Sharecare

David Perlmutter, MD 
Paid Consultant: Garden of Life 

Susan Sprich, PhD (Psychologist Reviewer)
Royalties: Oxford University Press; Springer
Honorarium for associate editor of a journal: Association for Behavioral and Cognitive Therapies

Rudolph Tanzi, MD
Paid Consultant and Financial Interest: Amylyx / AZTherapies / Promis  / Chromadex / Jupiter Neuroscience / Homecare Assistance 
Financial Interest: React Neuro / Cognitive Clarity / DRADS Capital / Verge Genomics / Cognoptix /  Genomind /  Interaxon / Neurogenetic Pharmaceuticals / ADvantage / Cerevance / MarvelBiome / Jefferson Pharmaceuticals / SiteRx / Acta Pharmaceuticals
Paid Consultant/Honoraria/Royalty: Takeda / FujiFilm / CAMP4 / Sarepta-Millenium Pharm. / Neurona/  Annovis  Bio / Dolby Foundation / Cure Alzheimer’s Fund / Boston U. / U.T. San Antonio / USC / Citadel / U. Miami / Virgin-Pulse / S.C. Johnson / Houston Methodist / New Age Media Ventures / Vida Ventures / YPO-Conn. / The Culinary Institute of America / MassGeneral Brigham / Motor Neuron Disease Association / Abide - Lundbeck La Jolla / MCI OPCA-A4M / Penguin-Random House / Sveriges Lantbruks U. / Inky Dink Productions / Sony Records / Roman Records / QR Pharma / Open Philantropy / Chopra Center-Markham Group

Expiration Date: May 31, 2027